# Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk

> **NCT02357368** · PHASE4 · COMPLETED · sponsor: **Lisa Haddad** · enrollment: 59 (actual)

## Conditions studied

- HIV
- Contraception

## Interventions

- **DRUG:** Depot medroxyprogesterone acetate (DMPA)
- **DEVICE:** Etonogestrel implant (Eng-Implant)
- **DEVICE:** Levonorgestrel intrauterine device (Lng-IUD)
- **DEVICE:** ParaGard® T 380A Intrauterine Copper Contraceptive

## Key facts

- **NCT ID:** NCT02357368
- **Lead sponsor:** Lisa Haddad
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2019-10-23
- **Final completion:** 2019-10-23
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2020-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02357368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02357368, "Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02357368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*